Comparison of efficacy of erythemal dose vs. suberythemal dose of excimer laser treatment in vitiligo
Not Applicable
Completed
- Conditions
- Diseases of the skin and subcutaneous tissue
- Registration Number
- KCT0004342
- Lead Sponsor
- Ajou University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Adult patients aged 18 years or older with stable vitiligo that was symmetrically distributed over their face and neck were recruited from our clinics
The stable vitiligo was defined as the absence of new lesions and no increase in the size of existing lesions for 6 months prior to the enrollment.
Exclusion Criteria
The exclusion criteria included the patients taking systemic corticosteroids or immunosuppressants for last 4 weeks; having chemotherapy or immunotherapy for last 4 weeks; having phototherapy including EL for last 4 weeks.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome was degree of repigmentation (%) from baseline in each side
- Secondary Outcome Measures
Name Time Method The degree of perilesional hyperpigmentation and patient preference